ArticleFrontiers in cell and developmental biology2021

Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer.

Pengju Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.